Jones Hill Capital’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.05M Buy
80,017
+22,917
+40% +$2.38M 1.2% 21
2026
Q2
$5.57M Buy
+57,100
New +$4.99M 1.18% 24

Other funds holding DNTH

Jones Hill Capital's DNTH Position: Q3 2026 in Review

Jones Hill Capital increased its Dianthus Therapeutics (DNTH) stake by 40% in Q3 2026, buying an estimated $2.38M and bringing the position to 80,017 shares worth $7.05M. The position accounts for 1.2% of the portfolio, ranked #21.

Jones Hill Capital first reported a position in DNTH in Q2 2026 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Jones Hill Capital held 80,017 shares of Dianthus Therapeutics worth $7.05M as of Q3 2026.
  • Jones Hill Capital bought 22,917 Dianthus Therapeutics shares in Q3 2026, an estimated $2.38M.
  • Dianthus Therapeutics made up 1.2% of Jones Hill Capital's portfolio in Q3 2026, its #21 holding.
  • Jones Hill Capital first reported a position in Dianthus Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Jones Hill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.